Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision tag on the page was updated from v3.6.2 to v3.6.3. This indicates a newer revision of the page or its associated documents rather than a change to study results or eligibility.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, showing a newer build of the page deployment. This indicates a small update to the page, likely a fix or minor enhancement without changing the study text.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded recruitment status text and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a page revision indicator (Revision: v3.6.0). Standardized the Intervention/Treatment heading by replacing 'Intervention / Treatment' and removed the older 'Revision: v3.5.5' tag.SummaryDifference0.4%

- Check33 days agoChange DetectedAdded related topics including Ovarian cancer and MedlinePlus Genetics, and updated the site revision from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check55 days agoChange DetectedA full bibliographic citation for an older study was added to the Publications section, and the revision tag Revision: v3.5.4 was included. The erratum note associated with that citation was removed from the Publications/related topics list.SummaryDifference0.2%

- Check69 days agoChange DetectedThe page's related topics metadata was updated to include 'Ovarian cancer' and 'MedlinePlus Genetics'. This change broadens how the study is indexed for ovarian cancer-related searches without altering the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.